How big is the North America Peripheral Embolization Coils Market?

The North America Peripheral Embolization Coils Market is valued at US$ 247.86 Million in 2023, it is projected to reach US$ 360.53 Million by 2031.

What segments are covered in this report?

The North America Peripheral Embolization Coils Market report typically cover these key segments- 类型（可拆卸弹簧圈、可推入弹簧圈）材质（铂金、铂金与水凝胶、铂钨合金）应用（出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏、静脉曲张）

What is the historic period, base year, and forecast period taken for North America Peripheral Embolization Coils Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Peripheral Embolization Coils Market report: 2025-2031 2023 2021-2023

Who are the major players in North America Peripheral Embolization Coils Market?

The North America Peripheral Embolization Coils Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Medtronic Plc ; Penumbra, Inc. ; Balt ; Boston Scientific Corp ; Cook Medical Holdings LLC ; Wallaby Medical ; Spartan Micro Inc. ; Terumo Corp

Who should buy this report?

The North America Peripheral Embolization Coils Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the North America Peripheral Embolization Coils Market value chain can benefit from the information contained in a comprehensive market report.

北美外周栓塞线圈市场（主要地区、市场参与者、规模和份额）- 预测至 2031 年

2023 年北美外周栓塞线圈市场价值 2.4786 亿美元，预计到 2031 年将达到 3.6053 亿美元；预计 2023 年至 2031 年的复合年增长率为 4.8%。

主动脉瘤丢失患病率上升推动北美外周栓塞线圈市场

主动脉瘤是人体主要动脉或主动脉的膨出壁。根据美国心脏协会 2023 年的数据，2020 年全球报告的 150,000 人死亡是由主动脉瘤引起的，比 2010 年增加了 26%。吸烟者和女性的动脉瘤破裂率更高。目前，尚无有效药物可预防主动脉瘤的发展；唯一的治疗选择是手术或血管内修复。栓塞剂常用于替代开放手术，而开放手术风险更高，且恢复期更长。外周血管栓塞线圈、氰基丙烯酸酯胶或纤维蛋白胶、凝胶泡沫和Onyx等栓塞装置常用于治疗主动脉瘤的内漏。栓塞线圈是一种合适的外周动脉瘤治疗方案，因为它比开放手术修复的创伤性更小。此外，在选择性治疗中，栓塞线圈还可用于治疗某些先天性心脏病、瘘管、动脉瘤以及冠状动脉搭桥术后的动脉侧支盗血综合征。因此，主动脉瘤患病率的上升推动了外周栓塞线圈市场的增长。

北美外周栓塞线圈市场概览

本文基于美国、加拿大和墨西哥的市场情况，对北美外周栓塞线圈市场进行了分析。结直肠癌和创伤患病率的上升是推动该地区市场增长的主要因素。结直肠癌是墨西哥第四大常见癌症，大多数病例发生在50岁以后，男女病例分布相似。因此，随着预期寿命的延长，新发病例数和死亡率也稳步上升。由于外周动脉疾病 (PAD) 和动脉瘤等血管疾病的患病率不断上升，需要微创治疗方案，美国外周栓塞线圈市场正在经历增长。外周栓塞线圈对于血管内栓塞至关重要，可以防止出血或减少目标区域的血流量。随着医疗保健提供者专注于通过微创手术改善患者预后，对这些线圈的需求正在上升。技术进步，例如更高效和生物相容性的线圈的开发，以及人们对血管内治疗的认识不断提高，正在进一步推动美国市场的扩张。

墨西哥的癌症发病率正在上升，结直肠癌是第三大常见癌症。据 IMSS 称，该国每年约有 15,000 例新发结肠癌病例。随着早期发现癌症运动的开展，墨西哥的结直肠癌市场预计将增长。据 GLOBOCAN 称，在墨西哥，2020 年胃癌的发病率为 6.2%，死亡率为每 100,000 人 4.7 人。微线圈栓塞是一种成熟的上消化道出血治疗方法，可在更靠近出血部位的地方进行。使用超选择导管进行的手术是治疗急性下消化道出血的安全有效的方法。据 Statista 统计，2021 年加拿大每 100,000 例住院病例中约 600 例是因创伤导致的。根据《加拿大外科杂志》（CJS）2021 年发表的一篇文章，经动脉栓塞术已成功用于治疗非脾脏创伤；最常见的栓塞技术是使用凝胶泡沫进行栓塞。这些手术成功率高，并发症发生率低。此外，加拿大卫生部已批准多种用于治疗颅内动脉瘤的线圈和线圈输送系统。线圈栓塞术可与其他辅助血管内装置（如支架和球囊）一起使用。

北美外周栓塞线圈市场收入及预测（至 2031 年）（百万美元）

北美外周栓塞线圈市场细分

北美外周栓塞线圈市场按类型、材料、应用和国家/地区分类。

根据类型，北美外周栓塞线圈市场分为可分离线圈和可推动线圈。2023 年，可分离线圈部分占有更大的市场份额。

就材料而言，北美外周栓塞线圈市场分为铂金、铂金和水凝胶以及铂钨合金。2023 年，铂金部分占有最大的市场份额。

根据应用，北美外周栓塞线圈市场细分为出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏和静脉曲张。2023 年，出血和创伤部分占有最大的市场份额。

根据国家/地区，北美外周栓塞线圈市场细分为美国、加拿大和墨西哥。 2023 年，美国占据了北美外周栓塞线圈市场的主导地位。

美敦力公司 (Medtronic Plc)、Penumbra, Inc.、Balt、波士顿科学公司 (Boston Scientific Corp)、库克医疗控股有限责任公司 (Cook Medical Holdings LLC)、Wallaby Medical、Spartan Micro Inc. 和 Terumo Corp. 是北美外周栓塞线圈市场的一些领先公司。

North America Peripheral Embolization Coils Strategic Insights

Strategic insights for North America Peripheral Embolization Coils involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-peripheral-embolization-coils-market-strategic-framework.webp

Get more information on this report

North America Peripheral Embolization Coils Report Scope

Report Attribute	Details
Market size in 2023	US$ 247.86 Million
Market Size by 2031	US$ 360.53 Million
Global CAGR (2023 - 2031)	4.8%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 类型（可拆卸弹簧圈、可推入弹簧圈） By 材质（铂金、铂金与水凝胶、铂钨合金） By 应用（出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏、静脉曲张）
Regions and Countries Covered	北美（美国、加拿大、墨西哥）北美（美国、加拿大、墨西哥）
Market leaders and key company profiles	Medtronic Plc Penumbra, Inc. Balt Boston Scientific Corp Cook Medical Holdings LLC Wallaby Medical Spartan Micro Inc. Terumo Corp

Get more information on this report

North America Peripheral Embolization Coils Regional Insights

The regional scope of North America Peripheral Embolization Coils refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.